Biotech News

Novan to Host Analyst and Investor Event: A Discussion of Molluscum's Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD

Novan (NOVN)Novan2023-04-20 09:00 ESTConference / presentation

Live moderated webcast with members of the Novan management team and dermatological key opinion leader, Dr. Jeffrey Sugarman on Tuesday, April 25th at 2:00 PM ET

DURHAM, N.C., April 20, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host an...

Novan

Novan was a dermatology-focused biotechnology company built around nitric oxide-based therapies for skin conditions and related inflammatory indications. Its story was centered on a narrow clinical platform and the challenge of turning topical science into a durable commercial path.

Recent company news

NOVNNovan2023-07-17 08:45 EST

Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection

NOVNNovan2023-06-05 09:00 EST

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Novan to Host Analyst and Investor Event: A Discussion of Molluscum's Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD

Related news

Novan to Present at the Virtual Investor 2023 Companies to Watch Event

Novan to Participate in the Virtual Investor Roundtable Event

Novan

Recent company news

Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

Novan Focuses Strategic Direction and Announces Restructuring

Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

Stock data